Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Gynaecological cancers

5039 - An increased ratio of cytotoxic to suppressive T cells after neoadjuvant chemotherapy (NACT) is prognostic in advanced ovarian cancer


09 Sep 2017


Gynaecological cancers


Ovarian Cancer


Aya Khairallah


Annals of Oncology (2017) 28 (suppl_5): v330-v354. 10.1093/annonc/mdx372


A. Khairallah1, A. Auguste2, A. Leary3, C. Genestie4, P. Pautier5, J. Michels3, P. Morice3, E. Bentivegna3, A. Maulard3, F. Drusch3, S. Mesnage5, S. Gouy5

Author affiliations

  • 1 Pathology, GUSTAVE ROUSSY, 94800 - Villejuif/FR
  • 2 Oncology, GUSTAVE ROUSSY, 94800 - Villejuif/FR
  • 3 Gynaecologic Oncology, Gustave Roussy Cancer Center, INSERM U981, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), 94800 - Villejuif/FR
  • 4 Department Of Pathology, Institut Gustave Roussy, 94800 - Villejuif/FR
  • 5 Medical Oncology, Gustave Roussy Institut de Cancérologie, 94805 - Villejuif/FR


Abstract 5039


At diagnosis, tumor-infiltrating lymphocytes (TILs) are prognostic in epithelial ovarian cancer (EOC). We recently demonstrated that neoadjuvant chemotherapy (NACT) significantly increased stromal TILs and stromal TILs remained prognostically significant after NACT. Here, we investigated the impact of NACT on different immune subpopulations and their relationship with clinical outcome.


Tissue microarrays of EOC (145 pre-NACT, 139 post-NACT, including 83 matched samples) were analyzed for CD3+,CD8+ and FOXP3+ by immunohistochemistry. Stromal TILs scored as percentage of stromal area, intraepithelial TILs as number of TILs in contact with tumor cells/HPF. Differences were evaluated by Mann-Whitney or Wilcoxon-signed-rank for unpaired or paired analyses, respectively and by Log-rank for PFS and OS.


NACT significantly increased stromal CD3 + (p = 0.005) and CD8 + (p = 0.009) and intraepithelial CD8 + (p = 0.02) infiltration in unmatched samples and remained significant among paired samples for stromal CD3+ and CD8 + (p = 0.03 and p = 0.009). Neither CD3+ nor CD8+ expression correlated with outcome at diagnosis or post-NACT, however reduced accumulation of FOXP3+ post-NACT (


NACT has a significant impact on the balance of cytotoxic versus suppressive T cells and a high ratio of CD8+/FOXP3+ post-NACT was most significantly associated with improved PFS and OS. Whether this could select patients for immune therapies in the post-operative setting should be investigated.

Clinical trial identification


Legal entity responsible for the study

Institut Gustave Roussy




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.